Home › Funds › Independent Franchise Partners LLP › BSX
Independent Franchise Partners LLP position in BSX
BOSTON SCIENTIFIC CORP · Health Care
Independent Franchise Partners LLP reported holding 3,542,946 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$154.6M, representing 0.96% of its reported portfolio and ranking #22 among its reported holdings. Independent Franchise Partners LLP first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Independent Franchise Partners LLP's BSX position evolved
Independent Franchise Partners LLP first disclosed a stake in BSX in Q3 2026 at 3,542,946 shares (US$154.6M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 3.54M | $154.65M | New |
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- PRIMECAP MANAGEMENT CO/CA/ 58.62M sh · $2.56B · Q3 2026
- MFS Investment Management 43.05M sh · $2.29B · Q3 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
More on Independent Franchise Partners LLP
FAQ
How long has Independent Franchise Partners LLP held BSX?
Independent Franchise Partners LLP has disclosed BSX holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Independent Franchise Partners LLP's current position in BSX?
As of Q3 2026, Independent Franchise Partners LLP holds 3.54M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $154.65M, representing 0.96% of its reported portfolio and ranking #22.
Has Independent Franchise Partners LLP been buying or selling BSX?
In the latest 13F filing (Q3 2026), Independent Franchise Partners LLP newly opened its position in BSX.
Which other funds hold BSX?
Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.